Navigation Links
SCOLR Pharma, Inc. Reports Third Quarter 2010 Financial Results
Date:11/10/2010

//www.scolr.com/.

This press release contains forward-looking statements (statements which are not historical facts) within the meaning of the Private Securities Litigation Reform Act of 1995, including statements concerning anticipated sales of our nutritional products and the timing thereof, the timing of anticipated shipment of our nutritional products, our expectations concerning conduct of the actual use study for our ibuprofen product, our expectations concerning regulatory approval of our pseudoephedrine product and the anticipated timing of such approval. These forward-looking statements involve risks and uncertainties, including activities, events or developments that we expect, believe or anticipate will or may occur in the future. A number of factors could cause actual results to differ from those indicated in the forward-looking statements, including lower than expected demand by national retailers for our nutritional products, our ability to conform to the sales planning cycles of the retailers targeted as potential customers for our nutritional products, constraints on our liquidity related to the greater working capital requirements of our nutritional business, unanticipated changes in the timing or amount of orders for our nutritional products, unanticipated problems or delays with our regulatory applications, unanticipated costs and expenses associated with our product development, clinical activities and regulatory review,  reductions in our royalty revenues, our ability to create and maintain partnerships or other relationships, the continuation of arrangements with our product development partners, customers and clinical project services providers, competition, government regulation and general economic conditions. For example, if we are not able to meet the timing and other expectations of the retailers we have targeted as potential customers of our nutritional products, we may not be able to generate revenue from sales of these
'/>"/>

SOURCE SCOLR Pharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director
2. SCOLR Pharma, Inc. Signs Agreement with The Emerson Group to Provide Sales Support for Nutritional & OTC Products
3. SCOLR Pharma, Inc. Enters into Worldwide Licensing Agreement with RedHill Biopharma Ltd.
4. SCOLR Pharma, Inc. Licenses Dietary Supplements
5. SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards
6. SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
7. SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results
8. SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen
9. Reportlinker Adds Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics, 4th edition
10. Reportlinker Adds Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 4th Edition
11. Horizon Pharma, Inc. Files Registration Statement for Proposed Initial Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... 2015 Roche,s Bloodhound technology is on ... in hematology testing, according to Kalorama Information.  The ... of its Bloodhound digital cell imaging technology –as ... hematology analyzer – is notable as a ... current leader CellaVision, but also compete more broadly ...
(Date:7/2/2015)... , June 26, 2015 Research ... "Vitamin D Market by Analog, Application, End-User & by ... to their offering. This market is projected to ... vitamin D in different applications and rising opportunities in countries ... , Italy , and ...
(Date:7/2/2015)... --  EVO Aesthetic Center and Wellness Spa prides ... in Lakeway, Texas and will ... Duality laser. The medical spa is focused on helping ... laser procedures. Their addition of the Astanza Duality will ... their tattoo regret. "The large number of ...
Breaking Medicine Technology:Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 3Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 2Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 3EVO Offers Advanced Laser Tattoo Removal With Astanza Duality In Lakeway, TX 2
... Technologies (OTC Bulletin Board: MCLN ), ... treatment and disposal of medical waste and the ... announced it has partnered with Triumvirate Environmental, a ... engineering and remediation. This agreement will enable Triumvirate ...
... Sequenom, Inc. (NASDAQ: SQNM ), a life sciences company ... results for the third quarter of 2011 after closing of the ... conference call hosted by Harry F. Hixson, Jr., Ph.D., Chairman and ... the same day at 5:00pm ET (2:00pm PT) and will be ...
Cached Medicine Technology:MedClean Technologies Partners With Triumvirate Environmental 2MedClean Technologies Partners With Triumvirate Environmental 3Sequenom, Inc. Announces Date of Third Quarter 2011 Financial Results and Conference Call 2
(Date:7/3/2015)... ... 2015 , ... Scientists at several top US cancer centers believe they now ... Click here to read the complete story , just posted on the Surviving ... Medical Center, and New York University exposed mice with a mutation on the tumor ...
(Date:7/3/2015)... ... 03, 2015 , ... B. E. Smith, the only full-service ... a national chief nursing officer recruitment for Jane Phillips Medical Center ... industry, B. E. Smith has recently placed more than 1,000 healthcare executives into ...
(Date:7/3/2015)... ... July 03, 2015 , ... Talcum powder attorneys representing ... their existing Talcum Powder Cancer Lawsuit Center website. Just as the previous version did, ... news , offering timely lawsuit updates and ovarian cancer warning information. The site is ...
(Date:7/3/2015)... ... ... " Selfie on a Stick ” was featured on NewsWatch as part of ... consumers. Amanda Forstrom, a technology expert and special reporter for NewsWatch, conducted the review ... Almost every smartphone has an incredibly powerful camera built into it. And when someone ...
(Date:7/3/2015)... ... 03, 2015 , ... The Celebrity Dresses is currently running a promotion through ... celebrities will have the opportunity to get 10% discount on orders that are over ... not have to use coupon codes or remember redemption codes. , There is ...
Breaking Medicine News(10 mins):Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 3Health News:Learn How to Take Selfies like Kendall Jenner 2Health News:Celebrity Fashion Summer Party Dresses on sale at TheCelebrityDresses.com 2
... Medical Corporation,(CRM:TSX-V) announced today for the year ended ... its Centers for Colorectal Health compared to,1,699 patient ... Commenting on this achievement, Edward Wright, CEO of ... strong demand for the CRH,O,Regan hemorrhoid banding technology ...
... LENEXA, Kan., Feb. 5 Mediware Information,Systems, Inc. (Nasdaq: ... blood and medication management, reported total revenue for the ... $11,262,000 in the,comparable quarter in fiscal year 2007. Net ... four cents per fully diluted share, compared to net,income ...
... Trade Center had sleeplessness, other problems, study shows , , ... to the World Trade Center terrorist attacks boosted behavioral ... by researchers at the Mount Sinai School of Medicine ... 4 years of age who lived in or attended ...
... New position created to support growth at MDS ... Nordion, a leading provider,of medical isotopes and radiopharmaceuticals, ... position of Senior Vice-President Innovation.,Dr. Covitz will lead ... strategies and identifying new complimentary business,opportunities to better ...
... Access to ... Treatment, NEW YORK, ... finding a cure for breast cancer, the Avon,Foundation will bring together nearly ... Breast Cancer Forum, held February 4-6,in Houston, TX. This year,s Forum, titled ...
... Inc. (Nasdaq:,FVRL), a biopharmaceutical company developing patient-specific, active,immunotherapies ... it will,host a conference call and live webcast ... 2008 to discuss the Company,s fourth quarter and ... be issued before the U.S.,stock markets open that ...
Cached Medicine News:Health News:CRH Medical Corporation announces substantial increase in patient visits 2Health News:Mediware Reports Second Quarter Fiscal 2008 Results 2Health News:Mediware Reports Second Quarter Fiscal 2008 Results 3Health News:Mediware Reports Second Quarter Fiscal 2008 Results 4Health News:9/11 Exposure Linked to Behavior Trouble in Kids 2Health News:Dr. Peter Covitz Joins MDS Nordion as Senior Vice-President Innovation 2Health News:Avon Foundation Brings Together Breast Cancer Experts in Houston to Report Significant New Data 2Health News:Avon Foundation Brings Together Breast Cancer Experts in Houston to Report Significant New Data 3Health News:Favrille to Host Conference Call and Live Webcast to Discuss Fourth Quarter and Year End 2007 Financial Results on February 19, 2008 2
The rubber, whistle tip catheter with thumb valve has two side eyes to help minimize trauma....
Extra Long Gentle Vactrol® Connector., ,Indications For Usage: ,Removal of secretions from respiratory tract....
Gentle-Flo® Vactrol® Connector., ,Indications For Usage: ,Removal of secretions from respiratory tract....
D-Line Coude' Suction Catheter., ,Indications For Usage: , Removal of secretions from respiratory tract , For ease and greater assurance of entering and suctioning the left bronchus ...
Medicine Products: